This article was originally published on Medtech Intelligence. Precision medicine, an emerging toolkit of ways to better understand the complex mechanisms underlying a patient’s health, disease, or condition, and to better predict which treatments will be most effective, has grown unevenly outside... Read More
In a draft guidance released in September 2019, Singapore’s Health Sciences Authority is seeking feedback from medical device industry stakeholders on the development of new regulations on next-generation sequencing (NGS) in vitro diagnostic devices. The proposed new regulations are limited to devices that... Read More
Seeking to ease access among patients in Singapore to urgently needed life-saving therapies, the Health Sciences Authority (HSA) in September 2019 announced a faster route to the approval of such critical imports. Under the new regulations, licensed hospitals or clinics, retail pharmacies,... Read More
As electronic labeling of pharmaceuticals and therapeutic products becomes more prevalent, Singapore’s Health Science Authority this summer issued guidelines to ensure the labeling systems provide needed information to consumers and regulators. The electronic labels—often dependent on USSD codes that link to labels... Read More
A growing number of Association of Southeast Asian Nations (ASEAN) member states are coming into compliance with medical device requirements they first pledged to work towards in 2015. Under the ASEAN Medical Device Directive (AMDD), the 10 ASEAN nations agreed to bring... Read More
The use of genetic or molecular profiling, known as precision medicine, is growing in popularity and usefulness throughout Asia, as doctors become more adept at selecting treatments that are most likely to help patients based on a genetic understanding of their disease.... Read More
As demand skyrockets for healthcare in Southeast Asia, remote medical provider technologies are becoming increasingly popular. The technologies, which include app-based medical consultations and other telehealth options, allow doctors to reach more patients, especially in remote areas where access to healthcare providers... Read More
This article was originally featured on Medtech Intelligence. As Asia’s prostate cancer burden grows, so do opportunities for Western medical device companies with products to diagnose and treat the disease. Leading Western medical device firms are moving into markets across the Asian... Read More
With Singapore continuing to attract top pharmaceutical companies, clinical research and biomedical manufacturing opportunities abound. Indeed between 2000 and 2015, the number of clinical research programs conducted in Singapore jumped by 30%. Today, six out of the top 10 drugs produced globally... Read More
With rates of hepatitis B infection higher in Asia than anywhere else on the globe, deaths from liver cancer are an overwhelmingly Asian phenomenon. Almost 80 percent of cases and deaths from liver cancer occur on the Asian continent, according to the... Read More